首页> 外国专利> Marker sequences for diagnosing and stratifying systemic sclerosis patients

Marker sequences for diagnosing and stratifying systemic sclerosis patients

机译:诊断和分层系统性硬化症患者的标记序列

摘要

The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.
机译:本发明涉及鉴定系统性硬化症的标志物的方法(也叫硬皮病; SSc),并且涉及借助该方法鉴定的标志物,其一方面可以区分SSc和其他自身免疫疾病,另一方面可以区分不同的SSc亚组。另一方面。本发明还涉及包含这些标记物的面板,诊断装置和测试试剂盒,以及它们的用途和应用,例如用于SSc的诊断,预后和治疗控制。本发明还涉及用于SSc的筛选和验证活性物质的方法。

著录项

  • 公开/公告号US10571477B2

    专利类型

  • 公开/公告日2020-02-25

    原文格式PDF

  • 申请/专利权人 PROTAGEN AG;

    申请/专利号US201515324470

  • 申请日2015-07-04

  • 分类号G01N33/68;G01N33/564;C07K16/18;C07K14/47;C07K16/40;

  • 国家 US

  • 入库时间 2022-08-21 11:28:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号